TA1-2040, T1-995, tissue engineering, microfluidic device, ischemia/reperfusion injury, syringe pump, liver-on-a-chip, vacuum chuck, epithelial–endothelial interface, vessel branching, organs-on-chips, nanogrooves, passive delivery, functional neuron imaging, organ-on-a-chip, lung epithelial cell, MEMS, drug absorption, strain, 3D cell culture system, mechanical cue, multi-culture, angiogenesis, high-throughput screening, fluoroelastomer, membranes, cell culture, paracellular/transcellular transport, beating force, microfabrication, drug hepatotoxicity, biomimetic oxidation, compression, microfluidics, surfactant protein, PDMS, neuronal cell networks, neuronal guidance, trans-epithelial electrical resistance, spheroid array, organ-on-a-chip (OOC), biomechanics, cell, organ-on-chips, organ-on-chip, stretch, shear stress, shear flow, image-based screening, drug metabolism, vascularization, human induced pluripotent Stem cell-derived cardiomyocytes (hiPS-CM), stress, barrier permeability, bio-mechanical property, cardiac 3D tissue, endothelial cell activation, organoid, silicon, lattice light-sheet microscopy, integrated pump, SH-SY5Y cells, thrombolysis, 3D cell culture, neuronal cells, drug efficacy, vascularized tumor model, History of engineering and technology

Recent advances in microsystems technology and cell culture techniques have led to the development of organ-on-chip microdevices that produce tissue-level functionality, not possible with conventional culture models, by recapitulating natural tissue architecture and microenvironmental cues within microfluidic devices.